MONOBENZONE contains a topical depigmenting agent indicated for the final depigmentation in extensive vitiligo. It is used to lighten skin in people with vitiligo permanently. Vitiligo is a disease that causes loss of skin colour in blotches.
MONOBENZONE contains Monobenzone that works by increasing the elimination of melanin (pigment molecules) from skin cells. It depigments darker areas around the areas of vitiligo and helps even out the colouring and appearance of the skin.
In some cases, MONOBENZONE may cause mild skin irritation, dryness or flaking of treated skin. Most of these side effects do not require medical attention and will resolve gradually over time. However, if the side effects persist or worsen, consult a doctor.
Do not use MONOBENZONE if you are allergic to any of its components. Consult the doctor if you are pregnant or breastfeeding. MONOBENZONE is not recommended for children. Keep the doctor informed about your health condition and medications to rule out any side effects/interactions.
Vitiligo
MONOBENZONE contains Monobenzone, a topical depigmenting agent indicated for the final depigmentation in extensive vitiligo. It is used to lighten skin in people with vitiligo permanently in patients with disseminated (greater than 50 per cent of body surface area) idiopathic vitiligo. MONOBENZONE works by increasing the elimination of melanin (pigment molecules) from skin cells. It depigments darker areas around the areas of vitiligo and helps even out the colouring and appearance of the skin.
Do not use MONOBENZONE if you are allergic to any of its components. MONOBENZONE is not recommended in Berloque dermatitis (hyperpigmentation caused by photosensitisation following the use of certain perfumes), freckling, melasma of pregnancy, malignant melanoma, hyperpigmentation resulting from inflammation of the skin, or pigmentation resulting from pigments other than melanin (artificial pigments, bile, silver). Consult your doctor if you are pregnant or breastfeeding. This medicine should not be used in children below 12 years. Let your doctor know if you are taking any prescription/non-prescription medicines, including supplements or herbal products.
Drug-Drug Interactions: No interactions found/established.
Drug-Food Interactions: No interactions found/established.
Drug-Disease Interaction: No interactions found/established.
It is not known whether alcohol interacts with MONOBENZONE. Please consult your doctor.
Monobenzone belongs to pregnancy category C. MONOBENZONE should be used during pregnancy only if clearly needed.
It is not known if Monobenzone passes into breast milk. Caution should be exercised while administering MONOBENZONE to a nursing woman.
-
Limited data is available. Please consult your doctor if you have concerns regarding the usage of MONOBENZONE in patients with liver impairment.
Limited data is available. Please consult your doctor if you have concerns regarding the usage of MONOBENZONE in patients with kidney impairment.
MONOBENZONE is not recommended for children below 12 years as the safety and effectiveness have not been established.
Vitiligo: Vitiligo is a disease that causes loss of skin colour in blotches. It occurs when the pigment-producing cells called melanin die or stop functioning. Vitiligo is generally considered to be an autoimmune disorder (the immune system attacks the body's own tissues and organs). It can affect any part of the skin; however, it mostly occurs on the face, neck, creases, and hands.